JP2023519932A5 - - Google Patents
Info
- Publication number
- JP2023519932A5 JP2023519932A5 JP2022559339A JP2022559339A JP2023519932A5 JP 2023519932 A5 JP2023519932 A5 JP 2023519932A5 JP 2022559339 A JP2022559339 A JP 2022559339A JP 2022559339 A JP2022559339 A JP 2022559339A JP 2023519932 A5 JP2023519932 A5 JP 2023519932A5
- Authority
- JP
- Japan
- Prior art keywords
- variant
- antibody
- cell
- targeting agent
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003219P | 2020-03-31 | 2020-03-31 | |
| US63/003,219 | 2020-03-31 | ||
| PCT/US2021/025166 WO2021202726A2 (en) | 2020-03-31 | 2021-03-31 | Anti-cd33 antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519932A JP2023519932A (ja) | 2023-05-15 |
| JP2023519932A5 true JP2023519932A5 (https=) | 2024-04-01 |
| JP7851255B2 JP7851255B2 (ja) | 2026-04-24 |
Family
ID=77929967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559339A Active JP7851255B2 (ja) | 2020-03-31 | 2021-03-31 | 抗ｃｄ３３抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230190810A1 (https=) |
| EP (1) | EP4126245A4 (https=) |
| JP (1) | JP7851255B2 (https=) |
| CN (1) | CN115297932A (https=) |
| CA (1) | CA3173213A1 (https=) |
| WO (1) | WO2021202726A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020232247A1 (en) | 2019-05-14 | 2020-11-19 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| CN121591894A (zh) * | 2024-08-23 | 2026-03-03 | 南京北恒生物科技有限公司 | 靶向cd33的抗体及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004272607B2 (en) * | 2003-09-11 | 2008-11-06 | Cornerstone Therapeutics Inc. | Monoclonal antibodies against HMGB1 |
| US20100150927A1 (en) * | 2006-07-13 | 2010-06-17 | Chugai Seiyaku Kabushiki Kaisha | Cell death inducer |
| US20130309223A1 (en) * | 2012-05-18 | 2013-11-21 | Seattle Genetics, Inc. | CD33 Antibodies And Use Of Same To Treat Cancer |
| SG11201604784XA (en) * | 2013-12-13 | 2016-07-28 | Genentech Inc | Anti-cd33 antibodies and immunoconjugates |
| CN108064245A (zh) * | 2015-04-17 | 2018-05-22 | 埃尔萨里斯生物技术公司 | 抗Tyro3抗体及其用途 |
| AU2016276981B2 (en) * | 2015-06-12 | 2022-10-06 | Alector Llc | Anti-CD33 antibodies and methods of use thereof |
| TW201800420A (zh) * | 2016-05-20 | 2018-01-01 | 艾伯維史坦森特瑞斯有限責任公司 | 抗ascl1抗體及使用方法 |
| WO2018014001A1 (en) * | 2016-07-14 | 2018-01-18 | Fred Hutchinson Cancer Research Center | Multiple bi-specific binding domain constructs with different epitope binding to treat cancer |
| US12116406B2 (en) * | 2017-05-26 | 2024-10-15 | Fred Hutchinson Cancer Center | Anti-CD33 antibodies and uses thereof |
| US20190038248A1 (en) * | 2017-08-04 | 2019-02-07 | Dentalaire Products Int'l | Veterinary X-ray Sensor and Boot |
| JOP20190116A1 (ar) * | 2018-05-24 | 2019-11-24 | Janssen Biotech Inc | الأجسام المضادة لتكتل التمايز 33 (cd33)، والأجسام المضادة ثنائية النوعية لتكتل التمايز 33 (cd33)/تكتل التمايز 3 (cd3) واستخداماتها |
-
2021
- 2021-03-31 CN CN202180021770.2A patent/CN115297932A/zh active Pending
- 2021-03-31 CA CA3173213A patent/CA3173213A1/en active Pending
- 2021-03-31 JP JP2022559339A patent/JP7851255B2/ja active Active
- 2021-03-31 EP EP21780080.4A patent/EP4126245A4/en active Pending
- 2021-03-31 WO PCT/US2021/025166 patent/WO2021202726A2/en not_active Ceased
- 2021-03-31 US US17/995,089 patent/US20230190810A1/en active Pending